4//SEC Filing
Nark Ted C 4
Accession 0001723128-19-000120
CIK 0001723128other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:53 PM ET
Size
5.0 KB
Accession
0001723128-19-000120
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Purchase
Class A Common Stock
2019-08-28$2.39/sh+50,000$119,500→ 56,107 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.38 per share to $2.44 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001316851
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:53 PM ET
- Size
- 5.0 KB